+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Continuous Manufacturing Market by Application, by Distribution Channel, and by End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

  • ID: 4854289
  • Report
  • September 2018
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

The report covers forecast and analysis for the pharmaceutical continuous manufacturing market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pharmaceutical continuous manufacturing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pharmaceutical continuous manufacturing market on a global level.

In order to give the users of this report a comprehensive view of the pharmaceutical continuous manufacturing market, we have included competitive landscape and analysis of Porter's Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein application, distribution channel, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, application portfolio of various companies according to region.

The study provides a decisive view of the pharmaceutical continuous manufacturing market by segmenting the market based on application type, distribution channel, end-users, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on application, the market is segmented into active pharmaceutical ingredient, biologics, and dry powders. Based on distribution channel type, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The end-users are classified into pharmaceutical companies and contract manufacturing organization. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of Middle East and Africa. This segmentation includes demand for pharmaceutical continuous manufacturing market based on individual application type, distribution channel, and end-users in all the regions and countries.

The report also includes detailed profiles of end players such as Siemens AG, Corning Life Sciences, S K Biotek Ltd., Scott Equipment Company, GEA Group, Korsch AG, Chemtrix, and Continuus Pharmaceuticals, among others.  

This report segments the global pharmaceutical continuous manufacturing market as follows:

Global Pharmaceutical Continuous Manufacturing Market: Application Segment Analysis

  • Active Pharmaceutical Ingredient
  • Biologics
  • Dry Powders

Global Pharmaceutical Continuous Manufacturing Market: Distribution Channel Segment Analysis

  • Hospital Pharmacy
  • Retail Pharmacy 
  • Online Pharmacy

Global Pharmaceutical Continuous Manufacturing Market: End-user Segment Analysis

  • Pharmaceutical Companies 
  • Contract Manufacturing Organization

Global Pharmaceutical continuous manufacturing Market: Regional 

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • The Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Pharmaceutical continuous manufacturing market, 2017 - 2024 (USD Million)
    • 2.2. Global Pharmaceutical continuous manufacturing market: snapshot
  • Chapter 3. Pharmaceutical continuous manufacturing Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Pharmaceutical continuous manufacturing market drivers: impact analysis
      • 3.2.2. Increased inefficiency in the manufacturing process
      • 3.2.3. Increased FDA initiatives
    • 3.3. Market Restraints
      • 3.3.1. Global Pharmaceutical continuous manufacturing market restraints: impact analysis
      • 3.3.2. Regulatory challenges
    • 3.4. Opportunities
      • 3.4.1. Rising regulatory supervision of manufacturing facilities
      • 3.4.2. Improving Pharma Infrastructure
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by application segment
      • 3.6.2. Market attractiveness analysis, by distribution channel segment
      • 3.6.3. Market attractiveness analysis, by end-users segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Pharmaceutical continuous manufacturing Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Pharmaceutical continuous manufacturing Market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Pharmaceutical continuous manufacturing Market- Application Segment Analysis
    • 5.1. Global Pharmaceutical continuous manufacturing Market: application overview
      • 5.1.1. Global Pharmaceutical continuous manufacturing market revenue share, by application , 2017 and 2024
    • 5.2. Active Pharmaceutical Ingredient
      • 5.2.1. Global Pharmaceutical continuous manufacturing market for Active Pharmaceutical Ingredient, 2017 - 2024 (USD Million)
    • 5.3. Biologics
      • 5.3.1. Global Pharmaceutical continuous manufacturing market for Biologics, 2017 - 2024 (USD Million)
    • 5.4. Dry Powders
      • 5.4.1. Global Pharmaceutical continuous manufacturing market for Dry Powders, 2017 - 2024 (USD Million)
  • Chapter 6. Global Pharmaceutical continuous manufacturing Market- Distribution channel Type Segment Analysis
    • 6.1. Global Pharmaceutical continuous manufacturing Market: Distribution channel type overview
      • 6.1.1. Global Pharmaceutical continuous manufacturing market revenue share, by Distribution channel, 2017 and 2024
    • 6.2. Hospital pharmacy
      • 6.2.1. Global Pharmaceutical continuous manufacturing market for Hospital pharmacy, 2017 - 2024 (USD Million)
    • 6.3. Retail pharmacy
      • 6.3.1. Global Pharmaceutical continuous manufacturing market for Retail pharmacy, 2017 - 2024 (USD Million)
    • 6.4. Online pharmacy
      • 6.4.1. Global Pharmaceutical continuous manufacturing market for Online pharmacy, 2017 - 2024 (USD Million)
  • Chapter 7. Global Pharmaceutical continuous manufacturing Market- End-user Segment Analysis
    • 7.1. Global Pharmaceutical continuous manufacturing Market: End-user overview
      • 7.1.1. Global Pharmaceutical continuous manufacturing market revenue share, by End-user, 2017 and 2024
    • 7.2. Pharmaceutical companies
      • 7.2.1. Global Pharmaceutical continuous manufacturing market for Pharmaceutical companies, 2017 - 2024 (USD Million)
    • 7.3. Contract manufacturing organization
      • 7.3.1. Global Pharmaceutical continuous manufacturing market for Contract manufacturing organization, 2017 - 2024 (USD Million)
  • Chapter 8. Global Pharmaceutical continuous manufacturing Market- Regional Segment Analysis
    • 8.1. Global Pharmaceutical continuous manufacturing Market: regional overview
      • 8.1.1. Global Pharmaceutical continuous manufacturing market revenue share, by region, 2017 and 2024
    • 8.2. North America
      • 8.2.1. North America Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
      • 8.2.2. North America Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
      • 8.2.3. North America Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.2.4.2. U.S. Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.2.4.3. U.S. Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.2.5.2. Rest of North America Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.2.5.3. Rest of North America Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
      • 8.3.2. Europe Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
      • 8.3.3. Europe Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.3.4.2. U.K. Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.3.4.3. U.K. Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.3.5.2. Germany Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.3.5.3. Germany Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.3.6.2. France Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.3.6.3. France Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.7. Italy
        • 8.3.7.1. Italy Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.3.7.2. Italy Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.3.7.3. Italy Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.8. Spain
        • 8.3.8.1. Spain Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.3.8.2. Spain Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.3.8.3. Spain Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.9. Rest of Europe
        • 8.3.9.1. Rest of Europe Pharmaceutical continuous manufacturing market revenue, by Application , 2017 - 2024 (USD Million)
        • 8.3.9.2. Rest of Europe Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.3.9.3. Rest of Europe Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
      • 8.4.2. Asia Pacific Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
      • 8.4.3. Asia Pacific Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.4.4.2. China Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.4.4.3. China Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.4.5.2. Japan Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.4.5.3. Japan Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.4.6.2. India Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.4.6.3. India Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.4.7. Southeast Asia
        • 8.4.7.1. Southeast Asia Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.4.7.2. Southeast Asia Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.4.7.3. Southeast Asia Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
      • 8.5.2. Latin America Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
      • 8.5.3. Latin America Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.5.4.2. Brazil Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.5.4.3. Brazil Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.5.5.2. Rest of Latin America Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.5.5.3. Rest of Latin America Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
      • 8.6.2. Middle East and Africa Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
      • 8.6.3. Middle East and Africa Pharmaceutical continuous manufacturing market revenue, by end user, 2017 - 2024 (USD Million)
      • 8.6.4. GCC Countries
        • 8.6.4.1. GCC Countries Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.6.4.2. GCC Countries Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.6.4.3. GCC Countries Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.6.5. South Africa
        • 8.6.5.1. South Africa Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.6.5.2. South Africa Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.6.5.3. South Africa Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.6.6. Rest of Middle East and Africa
        • 8.6.6.1. Rest of Middle East and Africa Pharmaceutical continuous manufacturing market revenue, by application , 2017 - 2024 (USD Million)
        • 8.6.6.2. Rest of Middle East and Africa Pharmaceutical continuous manufacturing market revenue, by distribution channel, 2017 - 2024 (USD Million)
        • 8.6.6.3. Rest of Middle East and Africa Pharmaceutical continuous manufacturing market revenue, by end-users, 2017 - 2024 (USD Million)
  • Chapter 9. Company Profile
    • 9.1. Siemens AG
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Corning Life Sciences
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. S K Biotek Ltd
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Scott Equipment Company
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. GEA group
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Chemtrix
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Continuous Pharmaceutical
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Korsch AG
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll